Brazil’s ANVISA voted on January 28, 2026 to approve five new cannabis resolutions–RDC 1,011 through RDC 1,015–marking the most significant regulatory shift in the country’s medical cannabis market since 2019. Here’s what each resolution means for producers and operators.
Read MoreGrowerIQ Becomes First International Seed-to-Sale Platform to Enter Brazil
GrowerIQ has become the first international seed-to-sale platform to formalize operations in Brazil through a strategic alliance with Milgrows, positioning compliance infrastructure ahead of ANVISA’s August 4, 2026 cultivation deadline.
Read MoreVAC Cuts Medical Cannabis Reimbursement Cap from $8.50/g to $6.00/g, Effective April 1
Veterans Affairs Canada reduces the medical cannabis reimbursement cap from $8.50/g to $6.00/g effective April 1, 2026. What LPs need to know and do now.
Read MoreGrowerIQ Renews GMP Compliance Through Independent Validation by RQC
GrowerIQ, a global leader in cannabis compliance and seed-to-sale software, is proud to announce that its core platform has been independently validated as GxP-compliant by RQC, a world-renowned GMP system validation and regulatory consultancy.
Read MoreBarbados Medicinal Cannabis Licensing Authority (BMCLA) and GrowerIQ Partner to Establish Cutting-Edge Cannabis Industry in Barbados
The Barbados Medicinal Cannabis Licensing Authority (BMCLA), the island’s regulatory body for the medicinal cannabis industry, and GrowerIQ, a leading cannabis technology company, are proud to announce a partnership to develop the cannabis industry in Barbados.
Read MoreThe BMLCA & GrowerIQ Team Up to Develop the Barbados Cannabis Industry
The BMCLA selected GrowerIQ as its technology partner, which will manage all production of Cannabis in Barbados.
Read More




